N-Fmoc-N-methyl-L-threonine is a protected, non-proteinogenic amino acid derivative. It features an N-terminal 9-fluorenylmethoxycarbonyl (Fmoc) protecting group and an N-methylated α-amino group on the L-threonine backbone. This structure is specifically designed for use in solid-phase peptide synthesis (SPPS). Its primary application is as a specialized building block in the synthesis of modified peptides, particularly in the pharmaceutical and life sciences research fields. The N-methylation introduces conformational constraints and can enhance metabolic stability, membrane permeability, and bioavailability of the resulting peptides. It is a crucial reagent for producing peptidomimetics and investigating structure-activity relationships in drug discovery. This compound is a staple in peptide chemistry laboratories. It is used under standard Fmoc-SPPS protocols, where the Fmoc group is removed with a base like piperidine to allow for chain elongation. Its availability supports the development of novel therapeutic peptides and bioactive probes.